In 2010, the U.S. Food & Drug Administration approved Pradaxa (Dabigatran Etexilate).  Pradaxa acts as a blood “thinner” and is promoted to reduce the risk of stroke and blood clots in people with atrial fibrillation.… Continue Reading →

Prescription errors

by on Monday, October 4, 2010  —  Blog, Prescription Errors

BE ALERT FOR MEDICATION ERRORS: Rarely a year passes without the announcement of some new wonder drug to treat another disease. While more and better drugs are usually considered a good thing, the increase in… Continue Reading →